ACP and partners to launch Covid-19 vaccine study for multiple sclerosis

Accelerated Cure Project (ACP) for multiple sclerosis (MS) is set to partner with Quest Diagnostics and the National Multiple Sclerosis Society to commence a study to assess the immune response of MS patients to Covid-19 vaccinations.